Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001841401-26-000003

Options or other derivatives

  • General Counsel acquired 44,471 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Wahl Bryan General Counsel 2026-03-05 Grant or award · Stock Option (right to buy) +27,310 27,310 D
Wahl Bryan General Counsel 2026-03-05 Grant or award · Restricted Stock Units +17,161 17,161 D
Loading xslF345X05/wk-form4_1773086812.xml…